Axogen Completes Acquisition of BioCircuit Technologies, Adding NerveTape™, the First FDA Cleared Device for Sutureless Peripheral Nerve Repair

Go back to Axogen Completes Acquisition of BioCircuit Technologies, Adding NerveTape™, the First FDA Cleared Device for Sutureless Peripheral Nerve Repair
AXOGEN (NASDAQ: AXGN) Delayed: 37.17 +0.69 (1.89%)
Previous Close $36.48    52 Week High $9.88 
Open $36.48    52 Week Low $4.52 
Day High $37.21    P/E N/A 
Day Low $36.30    EPS $-1.18 
Volume 226,786